Skip to main content

β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes.

Citation
Horwitz, E., et al. “Β-Cell Dna Damage Response Promotes Islet Inflammation In Type 1 Diabetes.”. Diabetes, pp. 2305-2318.
Center Vanderbilt University
Author Elad Horwitz, Lars Krogvold, Sophia Zhitomirsky, Avital Swisa, Maya Fischman, Tsuria Lax, Tehila Dahan, Noa Hurvitz, Noa Weinberg-Corem, Agnes Klochendler, Alvin C Powers, Marcela Brissova, Anne Jörns, Sigurd Lenzen, Benjamin Glaser, Knut Dahl-Jørgensen, Yuval Dor
Abstract

Type 1 diabetes (T1D) is an autoimmune disease where pancreatic β-cells are destroyed by islet-infiltrating T cells. Although a role for β-cell defects has been suspected, β-cell abnormalities are difficult to demonstrate. We show a β-cell DNA damage response (DDR), presented by activation of the 53BP1 protein and accumulation of p53, in biopsy and autopsy material from patients with recently diagnosed T1D as well as a rat model of human T1D. The β-cell DDR is more frequent in islets infiltrated by CD45 immune cells, suggesting a link to islet inflammation. The β-cell toxin streptozotocin (STZ) elicits DDR in islets, both in vivo and ex vivo, and causes elevation of the proinflammatory molecules IL-1β and Cxcl10. β-Cell-specific inactivation of the master DNA repair gene ataxia telangiectasia mutated (ATM) in STZ-treated mice decreases the expression of proinflammatory cytokines in islets and attenuates the development of hyperglycemia. Together, these data suggest that β-cell DDR is an early event in T1D, possibly contributing to autoimmunity.

Year of Publication
2018
Journal
Diabetes
Volume
67
Issue
11
Number of Pages
2305-2318
Date Published
12/2018
ISSN Number
1939-327X
DOI
10.2337/db17-1006
Alternate Journal
Diabetes
PMID
30150306
PMCID
PMC6198335
Download citation